Related Experiment Video
Updated: Aug 3, 2026
12:48
Construction of Cell-based Neurotransmitter Fluorescent Engineered Reporters CNiFERs for Optical Detection of Neurotransmitters In Vivo
Published on: May 12, 2016
13.1K
Ultra-Sensitive Biosensor Based on Cell-Derived Nanovesicles for CB1 Receptor-Targeted Drug Development in a Live
Minwoo Kim1, Hyungsup Kim2, Solpa Lee1
1Department of Medical and Digital Engineering, College of Engineering, Hanyang University, Seoul 04763, Republic of Korea.
Analytical Chemistry
|April 25, 2025
Summary
Scientists developed an ultrasensitive biosensor using cannabinoid receptor 1 (CB1) nanovesicles and carbon nanotubes. This novel sensor detects cannabinoid compounds at picomolar levels, offering a 1000-fold sensitivity improvement for drug screening.
Area of Science:
- Biotechnology
- Neuroscience
- Analytical Chemistry
Background:
- The endocannabinoid system, regulated by cannabinoid receptor 1 (CB1), influences key physiological functions like pain, mood, and appetite.
- CB1 is a therapeutic target for various disorders, but conventional detection methods lack sensitivity.
- Existing drug screening methods for CB1 operate in the nanomolar to micromolar range, necessitating more sensitive approaches.
Purpose of the Study:
- To develop an ultrasensitive biosensor for detecting cannabinoid compounds at lower concentrations.
- To improve upon the sensitivity limitations of current drug screening technologies for CB1-related therapeutics.
- To create a tool for high-throughput screening and therapeutic research targeting the endocannabinoid system.
Main Methods:
- Developed an ultrasensitive biosensor by coupling cell-derived CB1 nanovesicles (CB1-NV) with carbon nanotube (CNT)-printed electrodes.
- Utilized receptor-mediated Ca2+ influx as a signal transduction mechanism, converting it into measurable electrical signals.
- Employed cell-free vesicles to maintain the receptor's functional environment without requiring cell viability.
Main Results:
- The CB1-NV biosensor achieved picomolar detection limits for cannabinoid compounds, a significant increase in sensitivity.
- Demonstrated remarkable sensitivity by detecting trace amounts of tetrahydrocannabinol (0.001%) in hemp seed oil, undetectable by conventional methods.
- Achieved a 1000-fold improvement in sensitivity compared to traditional calcium imaging and patch-clamp techniques.
Conclusions:
- The developed ultrasensitive biosensor offers a promising platform for high-throughput drug screening and therapeutic research targeting the CB1 receptor.
- This technology overcomes the sensitivity limitations of conventional methods, enabling the detection of cannabinoids at trace levels.
- The cell-free nature of the biosensor simplifies experimental requirements by eliminating the need for cell viability maintenance.
